214 related articles for article (PubMed ID: 6968673)
21. Effects of beta-adrenergic blockade in an osteoblast-like cell line.
Majeska RJ; Minkowitz B; Bastian W; Einhorn TA
J Orthop Res; 1992 May; 10(3):379-84. PubMed ID: 1349041
[TBL] [Abstract][Full Text] [Related]
22. Conditionally immortalized murine osteoblasts lacking the type 1 PTH/PTHrP receptor.
Divieti P; Lanske B; Kronenberg HM; Bringhurst FR
J Bone Miner Res; 1998 Dec; 13(12):1835-45. PubMed ID: 9844101
[TBL] [Abstract][Full Text] [Related]
23. Human parathyroid hormone carboxyterminal peptide (53-84) stimulates alkaline phosphatase activity in dexamethasone-treated rat osteosarcoma cells in vitro.
Murray TM; Rao LG; Muzaffar SA; Ly H
Endocrinology; 1989 Feb; 124(2):1097-9. PubMed ID: 2912687
[TBL] [Abstract][Full Text] [Related]
24. Cross-talk of parathyroid hormone-responsive dual signal transduction systems in osteoblastic osteosarcoma cells: its role in PTH-induced homologous desensitization of intracellular calcium response.
Sugimoto T; Ikeda K; Kano J; Yamaguchi T; Fukase M; Chihara K
J Cell Physiol; 1994 Feb; 158(2):374-80. PubMed ID: 8106573
[TBL] [Abstract][Full Text] [Related]
25. Alkaline phosphatase inhibition by parathyroid hormone and isoproterenol in a clonal rat osteosarcoma cell line. Possible mediation by cyclic AMP.
Majeska RJ; Rodan GA
Calcif Tissue Int; 1982 Jan; 34(1):59-66. PubMed ID: 6279255
[TBL] [Abstract][Full Text] [Related]
26. Bone and kidney adenylate cyclase-stimulating activity produced by a hypercalcemic canine adenocarcinoma line (CAC-8) maintained in nude mice.
Rosol TJ; Capen CC; Brooks CL
Cancer Res; 1987 Feb; 47(3):690-5. PubMed ID: 3467838
[TBL] [Abstract][Full Text] [Related]
27. A newly established human osteosarcoma cell line with osteoblastic properties.
Kawai A
Clin Orthop Relat Res; 1990 Oct; (259):256-67. PubMed ID: 2170070
[TBL] [Abstract][Full Text] [Related]
28. Treatment of bone-derived ROS 17/2.8 cells with dexamethasone and pertussis toxin enables detection of partial agonist activity for parathyroid hormone antagonists.
McKee RL; Caulfield MP; Rosenblatt M
Endocrinology; 1990 Jul; 127(1):76-82. PubMed ID: 2163326
[TBL] [Abstract][Full Text] [Related]
29. Protein kinase C modulator effects on parathyroid hormone-induced intracellular calcium and morphologic changes in UMR 106-H5 osteoblastic cells.
Babich M; Foti LR; Mathias KL
J Cell Biochem; 1997 May; 65(2):276-85. PubMed ID: 9136085
[TBL] [Abstract][Full Text] [Related]
30. Proceedings: hormone-responsive adenylate cyclase in a transplantable osteogenic sarcoma in the rat.
Ingleton PM; Hunt NH; Underwood JC; Michelangeli VP; Crawford A; Martin TJ
J Endocrinol; 1976 Jun; 69(3):26P-27P. PubMed ID: 1065714
[No Abstract] [Full Text] [Related]
31. Alterations in hormone-sensitive adenylate cyclase of cloned rat osteosarcoma cells during long-term culture.
Gutierrez GE; Mundy GR; Katz MS
J Bone Miner Res; 1986 Aug; 1(4):319-26. PubMed ID: 2459911
[TBL] [Abstract][Full Text] [Related]
32. Insulin acutely suppresses parathyroid hormone second messenger generation in UMR-106-01 osteoblast-like cells: differential effects on phospholipase C and adenylate cyclase activation.
Iida-Klein A; Hahn TJ
Endocrinology; 1991 Aug; 129(2):1016-24. PubMed ID: 1855451
[TBL] [Abstract][Full Text] [Related]
33. Biochemical and morphological characterization of parathyroid hormone receptor binding to the rat osteosarcoma cell line UMR-106.
Mitchell J; Rouleau MF; Goltzman D
Endocrinology; 1990 May; 126(5):2327-35. PubMed ID: 2158423
[TBL] [Abstract][Full Text] [Related]
34. Activation of the parathyroid hormone receptor-adenylate cyclase system in osteosarcoma cells by a human renal carcinoma factor.
Nissenson RA; Strewler GJ; Williams RD; Leung SC
Cancer Res; 1985 Nov; 45(11 Pt 1):5358-63. PubMed ID: 2996759
[TBL] [Abstract][Full Text] [Related]
35. The 7-34-fragment of human hypercalcemia factor is a partial agonist/antagonist for parathyroid hormone-stimulated cAMP production.
McKee RL; Goldman ME; Caulfield MP; DeHaven PA; Levy JJ; Nutt RF; Rosenblatt M
Endocrinology; 1988 Jun; 122(6):3008-10. PubMed ID: 2836181
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a new human osteosarcoma cell line OHS-4.
Fournier B; Price PA
J Cell Biol; 1991 Aug; 114(3):577-83. PubMed ID: 1860886
[TBL] [Abstract][Full Text] [Related]
37. Tumor necrosis factor alpha modulates parathyroid hormone action in UMR-106-01 osteoblastic cells.
Hanevold CD; Yamaguchi DT; Jordan SC
J Bone Miner Res; 1993 Oct; 8(10):1191-200. PubMed ID: 8256656
[TBL] [Abstract][Full Text] [Related]
38. Skeletal alkaline phosphatase specific activity is an index of the osteoblastic phenotype in subpopulations of the human osteosarcoma cell line SaOS-2.
Farley JR; Hall SL; Herring S; Tarbaux NM; Matsuyama T; Wergedal JE
Metabolism; 1991 Jul; 40(7):664-71. PubMed ID: 1651438
[TBL] [Abstract][Full Text] [Related]
39. Glucocorticoid receptors and actions in subpopulations of cultured rat bone cells. Mechanism of dexamethasone potentiation of parathyroid hormone-stimulated cyclic AMP production.
Chen TL; Feldman D
J Clin Invest; 1979 Apr; 63(4):750-8. PubMed ID: 220282
[TBL] [Abstract][Full Text] [Related]
40. Measurement of cytosolic free Ca2+ concentrations in human and rat osteosarcoma cells: actions of bone resorption-stimulating hormones.
Boland CJ; Fried RM; Tashjian AH
Endocrinology; 1986 Mar; 118(3):980-9. PubMed ID: 3004904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
